Fibroblast growth factors (Fgfs) and their receptors have been implicated in embryonic pancreas development. Recently it was shown that Fgf10, a major ligand for the IIIb isoform of fibroblast growth factor receptor 2 (Fgfr2b), has an important regulatory role in early pancreas development. The aim of our study was to define the role of Fgfr2b in pancreas development by analyzing the phenotype of Fgfr2b (2/2) mice. Pancreases of Fgfr2b (2/2) embryos were noticeably smaller than the wild type littermates during embryogenesis, and pancreatic ductal branching as well as duct cell proliferation was significantly reduced. However, both exocrine and endocrine pancreatic differentiation occurred relatively normally. Exogenous addition of Fgfr2b ligands (Fgf7 and Fgf10) stimulated duct cell proliferation and inhibited endocrine cell differentiation in the ex vivo embryonic organ cultures of wild type pancreas. Our results thus suggest that Fgfr2b-mediated signaling plays a major role in pancreatic ductal proliferation and branching morphogenesis, but has little effect on endocrine and exocrine differentiation. q
Introduction
Mouse pancreas formation starts at embryonic day 8.5-9.5 when the dorsal pancreatic bud arises from foregut endoderm, followed soon after by the ventral bud. Pancreas development proceeds through a mechanism involving epithelial-mesenchymal interactions that regulate its growth, ductal branching and cell differentiation (Wessells and Cohen, 1967; Hellerstöm and Swenne, 1985) . The endoderm-derived epithelium undergoes two forms of morphogenesis, a branching morphogenesis to form the exocrine compartment and a budding off of epithelial cells that will eventually form islets (Percival and Slack, 1999) . The homeodomain transcription factor pdx1 appears to be an early marker for cells that will give rise to both these cell lineages. The exocrine cells differentiate to synthesize and secrete digestive enzymes such as amylase and carboxypeptidase A, while the endocrine cells secrete peptide hormones such as insulin and glucagon (Slack, 1995) .
Several receptor tyrosine kinases (RTKs) and their ligands are expressed in the developing pancreas, and are candidate signaling systems to mediate epithelial-mesenchymal interactions involved in organogenesis (Gittes et al., 1996; Miralles et al., 1998 Miralles et al., , 1999 Hart et al., 2000) . Fibroblast growth factors (Fgfs) belong to a family of at least 22 peptide growth factors that bind to and activate members of a family of tyrosine kinase receptors. Fgfs have been implicated in the regulation of cell differentiation, proliferation, migration and survival in a number of different cell types (Ornitz and Itoh, 2001) . Fibroblast growth factor receptors (Fgfrs) are encoded by four genes (designated as Fgfr1, -2, -3 and -4) that are characterized by two or three extracellular immunoglobulin (Ig)-like loops, a single transmembrane region, and cytoplasmic tyrosine kinase domain. Both second and third Ig-loops are involved in ligand binding. The third Ig-loop is encoded by two of three exons for Fgfrs 1-3, enabling the synthesis of alternately spliced isoforms of Fgfr2. The two different receptor isoforms of Fgfr2 are designated Fgfr2b and Fgfr2c. Fgfr2b is activated by Fgf1, Fgf3, Fgf7 and Fgf10 and is expressed predominantly in epithelia, while Fgfr2c binds Fgf1, Fgf2, Fgf4, Fgf6 and Fgf9, and is expressed mainly in cells of mesenchymal origin Orr-Urtreger et al., 1993) .
The importance of Fgfs and their receptors as regulators of vertebrate development has been demonstrated by gene targeting studies. Mice deficient for Fgfr1 die during gastrulation and deletion of both isoforms of Fgfr2 also leads to early lethality (Arman et al., 1998; Deng et al., 1994; Yamaguchi and Rossant, 1995) . Inactivation of Fgfr3 leads to skeletal dysplasia, while Fgfr4 deficient mice have no clear phenotype Deng et al., 1996; Weinstein et al., 1998) . The IIIb isoform of Fgfr2 (Fgfr2b) has been demonstrated as an important regulator of vertebrate organogenesis. The effect of inactivation of Fgfr2b on mouse development has been studied using dominant-negative receptors (Peters et al., 1994; Celli et al., 1998) , and by deleting the exon encoding Fgfr2b (De Moerlooze et al., 2000) . Fgfr2b (2/2) mice are viable until birth, but are unable to survive due to failed lung formation. They also have severe phenotypic abnormalities in many other organs. The homozygous mutant fetuses are smaller than their littermates, have no limbs and show other skeletal abnormalities also. They also lack eyelids and have agenesis of the mammary gland (Mailleux et al., 2002) and anterior pituitary. Development of the salivary gland and inner ear are also impaired (De Moerlooze et al., 2000; Pirvola et al., 2000) . The phenotype of mice deficient for Fgf10, closely resembles the one seen in Fgfr2b (2/2) mice (Ohuchi et al., 2000; Sekine et al., 1999; Min et al., 1998) .
Fgfs and their receptors have been implicated during embryonic pancreas development as well as in the function of adult b-cells. The expression of Fgfr1, Fgfr4 and Fgfr2b as well as some Fgfs, have previously been demonstrated in the developing rodent pancreas. (Le Bras et al., 1998; Miralles et al., 1999) Furthermore, rat E11.5 pancreases cultured with antisense oligonucleotides to Fgfr2b resulted in a reduced number of amylase producing exocrine cells (Miralles et al., 1999) , whereas exogenous addition of Fgf7 (a ligand for Fgfr2b) to rat E13.5 pancreatic epithelial cell cultures, induced epithelial growth and reduced endocrine differentiation (Elghazi et al., 2002 ). Recent findings demonstrate that Fgf10 is normally expressed in the mesenchyme surrounding the epithelial pancreatic buds from E9.5 to E11.5. Pancreatic development in Fgf10 null mice is severely disturbed mainly due to severely reduced proliferation of pdx1-positive pancreatic epithelial progenitor cells and subsequently a marked reduction in the number of islet cells expressing insulin (Bhushan et al., 2001) .
In this study, we present an extensive analysis of the pancreatic abnormalities exhibited by Fgfr2b (2/2) mice. The entire pancreas is substantially reduced in size and branching of the ductal tree is impaired, indicating that the main role of Fgfr2b-mediated signaling is in the development of the pancreatic ducts.
Results

Pancreas is smaller in Fgfr2b (2/2) embryonic mice than in wild type littermates
Mice deficient for Fgfr2b survive to term, but die at birth due to defective lung formation. In addition to defective lungs, these mice show several other abnormalities associated with organs that have a glandular structure. Analysis of pancreas development in Fgfr2b mutants at E12.5, E15.5 and E18.5 showed that while both dorsal and ventral pancreases developed, they were greatly reduced in size as compared to wild type littermates. This is illustrated by whole-mount in situ hybridization of the pancreas-specific pdx-1 gene (Fig. 1) . To determine the extent of the epithelial cell compartment, sections were stained with a pan cytokeratin (CK) antibody to visualize the basic branching morphology, and with Ki67 antibody to assess the level of cell proliferation (Fig. 2) . At E12-13, the number of CK positive ductal cells in mutants was less than half of that in wild type pancreases (225^24 ðn ¼ 4Þ versus 566^94 ðn ¼ 5Þ, P , 0:02). Also at E15.5, the number of CK positive cells was similarly reduced (4373^430 ðn ¼ 3Þ versus 9602^2276 ðn ¼ 3Þ, P , 0:08). There was an almost 2-fold reduction in the number of ductal lumens in the sections of E15.5 Fgfr2b (2/2) pancreases as compared to wild type (380^11 ductal lumens/mm 2 ðn ¼ 3Þ versus 626^32 ðn ¼ 3Þ, P , 0:002).
Pancreatic ductal cell proliferation was examined at E12 and E13 in wild type and mutant mice. Pancreases were sectioned through, and every seventh section was double stained for CK and Ki67, and the number of double-positive cells counted. The proliferation index of CK positive cells was significantly reduced in the Fgfr2b (2/2) mice (2.5^0.6% ðn ¼ 4Þ versus 5.0^0.7% ðn ¼ 5Þ, P , 0:04; see also Fig. 2 ).
Fgfr2b is expressed throughout the developing pancreas
Previous studies using Northern blotting have shown that Fgfr2b is expressed in the rat embryonic pancreas (Miralles et al., 1999) . To examine the spatial expression pattern of Fgfr2b, in situ hybridization with radioactive antisense probe specific to Fgfr2b was used on sections of E14.5 pancreas. As shown in Fig. 3 , Fgfr2b is expressed throughout the developing pancreatic tissue.
Endocrine and exocrine markers are expressed in Fgfr2b (2/2) pancreas
It has been suggested that Fgfr2b would be crucial for the proper differentiation of the exocrine pancreas (Miralles et al., 1999) , whilst its overstimulation has been suggested to inhibit endocrine pancreas differentiation (Elghazi et al., 2002) . Consequently, we have studied the expression pattern and the relative level of several transcription factors that are specific for the pancreatic endocrine or exocrine cells. We have used pdx1 as a general marker of the pancreatic epithelium, p48 as an exocrine cell marker, and ngn-3, pax6 and isl-1 as early endocrine markers. Analysis of these transcription factor markers by in situ hybridization showed them all to be expressed in both wild type and mutant pancreases at E14.5 and E15.5 ( Fig. 1 and Fig. 4) . The relative expression level of ngn-3 (a pro-endocrine transcription factor), Nkx6.1 (a b-cell specific transcription factor) and p48 (an exocrine specific transcription factor) at E15.5 was studied by Northern blotting. Expression levels were normalized to housekeeping gene cyclophilin expression levels. Relative expression of all three genes was reduced by approximately 50% in the mutant pancreas (Fig. 5) .
To confirm the presence of specific differentiated cell Fig. 3 . Fgfr2b is expressed in the E14.5 pancreas. In situ hybridization of E14.5 wild type pancreas with mouse Fgfr2IIIb probe was performed to study its expression pattern in developing mouse pancreas. Fgfr2IIIb seems to be expressed throughout the developing pancreatic tissue. types, sections were also immunohistochemically stained for endocrine cell markers (insulin, glucagon, somatostatin, pancreatic polypeptide) and exocrine (amylase) cells ( Fig. 2 and not shown). We found that all of these pancreatic proteins were present both in wild type and mutant pancreases of E18.5 embryos, indicating that differentiation of both the endocrine and exocrine compartments had occurred.
Pancreatic development in explant culture
We used an organ culture model (Miettinen et al., 2000) to study the ex vivo development of Fgfr2b (2/2) pancreases and the effects of exogenous Fgfr2b ligands on wild type pancreas development. Proliferation of pancreatic epithelium was studied at day one. In addition, the number of endocrine cells expressing insulin or glucagon, exocrine cells (amylase positive) and ductal (cytokeratin positive) cells was studied from explants cultured for 5 days. Initially at day 0, the explant cultures showed the presence of several ductal, some glucagon, few insulin and no amylase expressing cells. During the 5 days in culture, both exocrine and endocrine cells had developed, reminiscent of normal pancreatic differentiation (Table 2) .
After 1 day in culture, the proliferation of CK positive cells was significantly reduced in Fgfr2b (2/2) explants (Table 1) . After 5 days culture the mutant explants contained fewer cells than wt explants and especially the number of cytokeratin (ductal) cells was markedly reduced. Also the proportion of ductal cells was lower in the mutant explants (Table 2 ). There were also significantly fewer insulin positive cells in the Fgfr2b (2/2) explants whereas the number of amylase positive cells was similar or even higher. Since the total cell number was much lower in the mutant explants, the proportion of b-cells was not different, but that of exocrine amylase containing cells was significantly higher in the mutants (Table 2) .
Incubation of wild type pancreatic explants with Fgf7 and Fgf10, the ligands for Fgfr2b, also reduced the number of endocrine (insulin and glucagon positive) cells after 5 days in culture. However, no obvious effects were detected in the differentiation of the exocrine cells. The wild type explants cultured with Fgf7 or Fgf10 showed increased ductal cell proliferation after 1 day of culture (Table 1) , but surprisingly, they were not larger than the untreated controls after 5 days of culture (Table 2) .
Discussion
In the present study, we have focused on the role of Fgfr2b signaling in embryonic pancreas development. Our results demonstrate that while islet cell types and exocrine cells differentiate in Fgfr2b (2/2) pancreases, the organ as a whole is significantly smaller than those of the wild type littermates. A quantitative analysis of cytokeratin-positive ductal cells showed that there was a significantly reduced number compared to wild type embryos at all developmental stages studied. Moreover, the reduction of cell numbers correlated with a decrease in cell proliferation, and resulted in a poorly developed ductal tree. However, the in situ analyses showed that the transcription factors with implied Fig. 5 . The mRNA levels of ngn-3, p48 and Nkx6.1 are reduced in Fgfr2b (2/2) pancreas. mRNAs from E15.5 Fgfr2b (2/2) and wild type (1/1) pancreases were subjected to northern analysis using ngn-3, p48 and nkx6.1 probes. The mRNA loading was normalized to cyclophilin mRNA expression. Lower panel shows the relative intensity of expression of ngn-3, p48 and nkx6.1 after normalization to cyclophilin expression. Expression in wild type is equal to 100. 11.868^1.959* a Explants were then sectioned through and every seventh section was double-stained for cytokeratin and Ki67 to study the proliferation of pancreatic epithelium. (*P , 0:05; n ¼ number of explants). roles in exocrine or endocrine differentiation appeared to be expressed normally, albeit at lower levels. These findings emphasize the role of Fgfr2b mediated signaling in the proliferation of pancreatic progenitor cells and in consequent branching morphogenesis of the pancreas, rather than in its differentiation.
Pancreas formation in the mouse is first apparent at E8.5-E9.5 when the dorsal pancreatic bud arises from the gut endoderm. This is followed several hours later by evagination of the ventral bud a process believed to involve the notochord, which secretes inducing molecules. Both Fgf2 and activinb-B have been implicated and are thought to repress the expression of sonic hedgehog (Shh) in dorsal pre-pancreatic epithelium (Hebrok et al., 1998) . The repression of Shh correlates with the appearance of the dorsal pancreatic anlagen. Subsequently, the epithelial cells in dorsal and ventral pancreatic buds proliferate, resulting in ductal elongation and branching within the surrounding mesenchyme. This process is probably driven by growth factors derived from the mesenchyme acting on the epithelial buds. (Kim and Hebrok, 2001 ) The identity of these factors is not known, and is not likely to involve Fgfr2b signaling, since the initial stage of pancreatic development occurs normally. However, it is clear that signaling through Fgfr2b is critical for organogenesis since both the ductal cells as well as the endocrine compartment cells are depleted in mice deficient for Fgfr2b. This suggests that Fgfr2b signaling is necessary for cell proliferation at an early branching stage of developing pancreas, before a choice between endocrine and exocrine cell fates has been made. These findings are consistent with studies on mice lacking a functional Fgf10 gene that also develop a hypoplastic pancreas (Bhushan et al., 2001) . Hence, Fgf10 is probably the major mesenchymal ligand acting through epithelial Fgfr2b to stimulate proliferation, since mice deficient for Fgf7 have no reported pancreatic defect (Guo et al., 1996) . However, there are marked differences between the FgfR2b and Fgf10 deficient phenotypes. The branching defect in receptor-deficient pancreases is moderate as compared to the one seen in Fgf10-deficient pancreases. Furthermore, in contrast to Fgf10 (2/2) mice, the differentiation potential of both endocrine and exocrine precursor cells, remains essentially intact in Fgfr2b (2/2) pancreases. Moreover, in Fgf10 mutant embryos, expression of pdx1 is not detected throughout the pancreatic epithelium at E13.5, but is found in Fgfr2b deficient mice at E15.5. Hence, it is likely that pathways other than direct stimulation of the Fgfr2b are involved in Fgf10 action in the developing pancreas, perhaps involving Fgfr1b that also can be activated by Fgf10 (Lu et al., 1999) and is expressed on the developing pancreatic epithelium .
Mice over-expressing Fgf10 under the pdx1 promoter have increased proliferation of pancreatic epithelium and subsequently hyperplasia of the pancreas (Hart et al., 2001) . However, as is the case in Fgf10 deficient mice (Bhushan et al., 2001) , the numbers of differentiated endocrine cells are also reduced in the pdx1/Fgf10 mice (Hart et al., 2001 ). An in vitro increase in the proliferation of pancreatic endocrine progenitor cells, but a decrease in the number of differentiated endocrine cells by exogenous stimuli of Fgfr2b has also been demonstrated (Elghazi et al., 2002) . These findings are in accordance with the results obtained here, indicating that both lack of Fgfr2b and over-stimulation of it by its ligands have negative effects on pancreatic endocrine differentiation. Thus, it appears that Fgfr2b and its ligands play a crucial role in maintaining the proper mass of endocrine pancreatic precursor cells.
Some previous results indicate that Fgfr2b and its ligands are particularly important for exocrine pancreatic differentiation (Miralles et al., 1999) . However, the results obtained here in mice completely lacking this receptor show that there is no impairment of exocrine differentiation. In contrast, we have observed that the development of exocrine cells was even better preserved than that of other pancreatic cell types. Thus, Fgfr2b signaling is not required for exocrine differentiation, whereas normal activity of this receptor appears to be necessary for the proper development of the islets.
Fgfs have also been implicated in the regulation of b-cell function. Several Fgfs (Fgf1, Fgf2, Fgf4, Fgf5, Fgf7 and Fgf10) are expressed in adult mouse b-cells and IIIc isoform a Pancreases are sectioned through, and every seventh consecutive section stained with the same primary antibody, and the number of positive cells was counted from all sections. (n ¼ number of explants, *P , 0:05, **P , 0:01, ***P , 0:001,^SE).
of Fgfr1 is essential for proper b-cell function in the adult mouse. Mice expressing a dominant-negative Fgfr1c construct under the pdx1 promoter became diabetic by the age of 10 weeks. They had an atypical islet organization and 25% decrease in b-cell number, but no increase in beta-cell apoptosis. Expression of several functionally important bcell genes, such as GLUT-2 and PC1/3, was downregulated. A similar dominant-negative approach was used to study the effect of Fgfr2b attenuation. However, these mice had a normal pancreatic phenotype both as newborns and adults and had no signs of diabetes development (Hart et al., 2000) . This is in agreement with the notion that the main role of Fgfr2b in the pancreas is exerted in the progenitor cells and not in the differentiated cell populations. However, expression of Fgfr2b was detected also in the mature b-cells (Hart et al., 2000) . The possible physiological role of this remains unclear.
In conclusion, our results emphasize the role of Fgfr2IIIb mediated signaling in the proliferation of pancreatic ductal cells and in the proper branching of the pancreatic epithelium, as well as in the maintenance of the correct balance of endocrine to exocrine precursor cells.
Materials and methods
Generation and genotyping of Fgfr2b (2/2) mice
The targeted disruption of Fgfr2b, and the genotyping of offspring by PCR analysis of genomic yolk sac DNA has been described previously (De Moerlooze et al., 2000) . Mutant and wild type littermates were collected at E12.5, 13.5, 14.5, 15.5 and 18.5 for histological and in situ analysis, at E15.5 for RNA analysis and at E12.5 for pancreas organ cultures. The study was approved by the Haartman Institute Ethical committee for Animal Studies.
Histological analysis
Samples were fixed in Bouin's fixative and processed into serial paraffin sections using routine procedures. For general morphology, deparaffinized sections were stained with haematoxylin and eosin. The sections were then examined, photographed or morphometrically analyzed directly under light microscope. E15.5 pancreases were used for the analysis of ductal branching. For this purpose whole pancreases were sectioned through and number of ductal lumens was counted under the light microscope from every 20th section (six to eight sections/each pancreas) using a 10 mm grid. The number of ductal openings/mm 2 was then calculated.
Pancreatic organ cultures
Pancreatic explant cultures from both wild type and Fgfr2b deficient E12.5 embryos were used to study the in vitro development of the pancreas. The duodenal loop along with the pancreatic anlage and stomach were microdissected. The tissues were then cultured by a technique originally designed for embryonic kidney (Saxen and Lehtonen, 1987) . Tissue explants, consisting of dorsal and ventral pancreatic buds (mesenchyme plus epithelium), stomach and duodenal loop, were placed on Nucleopore filters (1.0 mm pore size, Costar) on metal grids and cultured at the air-liquid interphase in serum-free I-MEM (improved eagle's minimum essential medium, Gibco) supplemented with transferrin (30 mg/ml), penicillin (100 IU/ml) and streptomycin (100 mg/ml) and with or without Fgf7 (50 ng/ml) or Fgf10 (50 ng/ml). The media were changed every second day. After 1 or 5 days in culture, explants were fixed for 4 h at room temperature (RT) in Bouin's fixative. After rinsing with 50% alcohol, tissues were stored in 70% alcohol prior to dehydration and paraffin embedding.
Immunohistochemistry
For quantitative morphometric analysis of endocrine cell types, the entire tissue block was sectioned for immunostaining. Every seventh section was stained with the same primary antibody. Deparaffinized, rehydrated sections were first incubated in Ultra Vision blocking reagent (Lab Vision, Fremont, CA) at RT for 10 min to block nonspecific binding sites and then incubated with the primary antibody (guinea pig anti-porcine insulin 1:200, rabbit anti-human glucagon 1:800, rabbit anti-human somatostatin 1:600, rabbit antihuman pancreatic polypeptide 1:600; DAKO, rabbit antihuman amylase 1:200, mouse monoclonal anti-pan cytokeratin 1:200; Sigma) diluted in PBS containing 3% normal goat serum (Zymed, San Francisco, CA) for 1 h at RT. All antisera were pretested for optimal dilutions and staining conditions. After rinsing several times with PBS, sections were incubated with biotinylated-goat anti-rabbit (ready-touse, Lab Vision) or biotinylated-goat anti-mouse (ready-touse, Lab Vision) for 20 min at RT, rinsed and incubated with streptavidin peroxidase (ready-to-use, Lab Vision) for 10 min at RT. The sections were finally developed with AEC substrate (Lab Vision) and counterstained with haematoxylin.
After the immunohistochemical staining of every seventh section with the same pancreas-specific antibody (insulin, glucagon, somatostatin, PP, amylase and CK) the number of positively stained cells was manually counted under the light microscope (for E12, E13 and E15.5 pancreases and for the explant cultures).
Proliferating cells were detected using a rabbit antiserum to NCL-Ki67p (Novocastra, UK), that detects nuclei of the cells in the S-phase. For double staining of hormone plus Ki67, the staining protocol was continued from the one described above. The slides were treated with 10 mM citrate buffer (pH 6.0) and microwaved for 25 min to reveal antigenic sites and rinsed in PBS. Double staining was performed using the Vectastain ABC-kit (Vector, Burlingame, CA). The sections were incubated for 10 min at RT with Ultra Vision blocking reagent to block nonspecific binding sites and incubated with rabbit polyclonal Ki67 antibody (NovoCastra, Newcastle, UK) for 1 h at RT, diluted 1:500 in PBS containing 3% goat serum. After rinsing with PBS, sections were incubated for 30 min with biotinylated antibody, rinsed, incubated for 30 min in Vectastain ABC-alkaline phosphatase (AP) reagent, rinsed, and developed with AP substrate (Vector Blue). After color development, slides were rinsed in distilled water and mounted with Aquamount.
RNA analysis and probes
Total RNA from the Fgfr2b (2/2) and wild type E15.5 mouse pancreases was purified using Gen Elute Mammalian Total RNA Kit (Sigma). Total RNA (approximately 10 mg/ lane) was fractionated on a 1.2% formaline-agarose gel and transferred to a nylon membrane (Hybond-N, Amersham) by capillary blotting. The cDNA probes were 32 P-labelled by a random priming method (Prime-A-Gene Labeling System, Promega). Hybridizations were done in buffer containing 1% SDS, 1 M NaCl, and 8% dextran sulfate overnight at 658C. The blots were washed at 658C in 1 £ SSC and finally in 0.5 £ SSC. Hybridization signals were visualized using a Bio-imaging analyzer (Fuji Photo Film Co., Ltd). cDNA clones used for probe generation were kindly provided by following investigators: Dr Helena Edlund, Umeå, Sweden (mouse ngn-3); Dr Ole Madsen, Gentofte, Denmark (rat Nkx6.1); Dr Peter Wellauer, Lausanne, Switzerland (mouse p48); Dr Chris Wright, Nashville, TN, USA (mouse pdx-1); Dr Peter Gruss, Göttin-gen, Germany (mouse Pax6) and Dr Samuel Pfaff, La Jolla, USA (rat Islet 1). The hybridization signals were normalized against the housekeeping gene cyclophilin (Bergsma et al., 1991) .
In situ hybridization, whole mount in situ hybridization and probes: In situ hybridization was performed on deparaffinized tissue sections essentially as described previously (Kettunen and Karavanova, 1998) . The sections were hybridized with 10 6 cpm of [ 35 S]-labelled antisense riboprobes, prepared using the following murine cDNA templates: pdx1 p48, ngn3, Pax6, Fgfr2b and rat Islet 1. Whole mount in situ hybridization was performed as described (Revest et al., 2001) . Digoxigenin-labelled mouse pdx1 cDNA was used for the hybridization.
Statistics
Results are presented as the mean^SEM. Significance of observed differences between experimental groups were tested by one-way ANOVA followed by Fischer's PLSD test, or in the case of two groups, by Student's unpaired t test, using Statview 5.0 software (SAS institute, Cary, NC).
